Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors
AbstractInhibitors of human lactate dehydrogenase (hLDH5)—the enzyme responsible for the conversion of pyruvate to lactate coupled with oxidation of NADH to NAD+—are promising therapeutic agents against cancer because this enzyme is generally found to be overexpressed in most invasive cancer cells and is linked to their vitality especially under hypoxic conditions. Consequently, significant efforts have been made for the identification of small-molecule hLDH5 inhibitors displaying high inhibitory potencies. X-ray structure of hLDH5 complexes as well as molecular modeling studies contribute to identify and explain the main binding modes of hLDH5 inhibitors reported in literature. The purpose of this review is to analyze the main three-dimensional interactions between some of the most potent inhibitors and hLDH5, in order to provide useful suggestions for the design of new derivatives. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 3385 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Poli, G.; Granchi, C.; Aissaoui, M.; Minutolo, F.; Tuccinardi, T. Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors. Molecules 2017, 22, 2217.
Poli G, Granchi C, Aissaoui M, Minutolo F, Tuccinardi T. Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors. Molecules. 2017; 22(12):2217.Chicago/Turabian Style
Poli, Giulio; Granchi, Carlotta; Aissaoui, Mohamed; Minutolo, Filippo; Tuccinardi, Tiziano. 2017. "Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors." Molecules 22, no. 12: 2217.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.